全球肾结石治疗市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

肾结石治疗市场成长驱动因素

2025年，全球肾结石治疗市场规模为19.8亿美元。预计到2026年，该市场将成长至20.9亿美元，到2034年将达到33.7亿美元，这反映了在疾病盛行率上升和微创治疗广泛应用的推动下，该市场正稳步扩张。北美地区引领肾结石治疗市场，2025年占据36.03%的市场。这得益于先进的医疗基础设施、高诊断率以及充足的高科技医疗设备供应。

肾结石影响相当一部分成年人，其10年復发率超过30%。肥胖、糖尿病、高血压和久坐不动的生活方式日益普遍，增加了结石形成的风险，推动了医院和门诊对肾结石治疗设备的持续需求。

市场驱动因素与成长因素

微创手术技术的日益普及是肾结石治疗市场最强的驱动因素之一。输尿管镜碎石术、体外震波碎石术和经皮肾镜取石术等手术因其术后疼痛减轻、併发症发生率降低、住院时间缩短和恢復速度加快等优势而广泛采用。外科医生逐渐减少开放性手术，提高了手术量和设备利用率。

柔性光纤输尿管镜、数位影像系统和雷射碎石平台等技术进步提高手术精度和临床成功率。高能钬雷射系统等创新技术能够有效碎石，同时最大限度地减少对周围组织的损伤，改善治疗效果，并鼓励医院投资先进的泌尿外科设备。

市场限制与挑战

儘管技术不断进步，但某些治疗方法仍存在局限性。体外震波碎石术（ESWL）存在一些风险，包括肾组织损伤、出血、尿路阻塞和潜在的动脉血压升高。这些副作用在某些情况下可能会限制患者和医生的选择，并阻碍其在复杂结石病例中的广泛应用。

此外，成本障碍也会影响发展中地区的推广，因为这些地区的医疗预算有限，且难以获得先进的手术设备。此外，农村医疗机构（尤其是在新兴经济体）缺乏专业的泌尿外科基础设施，也限制了病患获得治疗的机会。

新冠疫情对市场的影响

新冠疫情暂时中断了肾结石治疗服务。择期泌尿外科手术被推迟，诊断咨询减少，医疗资源被重新分配到急诊和感染控制。医疗器材生产和全球供应链也放缓，导致设备采购延迟。虽然疫情后需求恢復，但手术积压导致医院和门诊手术中心的医疗器材使用量出现短期波动。

市场区隔分析

依类型

此市场细分包括体外震波碎石术、输尿管镜检查和经皮肾镜取石术（PCNL）。其中，输尿管镜检查将占据领先地位，到2026年将占市场占有率的51.59%。这项优势主要得益于其较高的结石清除率、较低的復发风险以及对中小结石的高度适用性。内视镜的灵活性、影像清晰度和雷射相容性的不断提升，推动其进一步普及。

依最终使用者划分

依最终使用者划分，市场由医院、专科诊所和门诊手术中心组成。医院将占据最大的市场占有率，到2026年将占市场占有率的55.89%，这主要得益于其庞大的患者数量、完善的手术设施以及广泛的保险覆盖范围。专科诊所因其在泌尿外科领域的专业知识、不断扩大的门诊手术能力以及某些国家优惠的偿付政策而备受关注。

依地区划分的市场趋势

北美

预计到2025年，北美市场规模将达到7.1亿美元，凭藉较高的诊断普及率、有利的偿付制度以及技术的快速普及，北美将继续保持其区域领先地位。受微创手术的广泛应用和较高的疾病盛行率推动，美国肾结石治疗市场预计到2026年将达到6.8亿美元。

欧洲

欧洲是第二大地区，其市场规模主要受发病率和医疗保健支出成长的推动。预计2026年，德国市场规模将达到1.6亿美元，英国市场规模将达7,000万美元。这得归功于先进泌尿外科设备的高度普及以及公共医疗保健网路中完善的转诊系统。

亚太地区

由于患者群体庞大且医疗服务可及性不断提高，亚太地区预计将实现显着成长。到2026年，中国市场预计将达到 1.4亿美元，日本市场将达到 1.1亿美元，印度市场将达到 5,000万美元。人们健康意识的提高、医院投资的增加以及私人医疗服务的扩张，推动城市治疗中心对相关设备的需求。

拉丁美洲、中东和非洲

在医疗基础设施改善和疾病认知度提高的推动下，这些地区正经历温和成长。医院网路的扩展和国际医疗器材合作改善肾结石治疗技术的可近性。

竞争格局与产业趋势

该市场由Boston Scientific Corporation、Olympus Corporation、KARL STORZ SE & Co. KG、Richard Wolf GmbH、Cook Medical、Lumenis、EDAP TMS等公司引领。这些公司凭藉着多元化的产品组合、持续的技术创新和策略联盟，保持着强大的全球影响力。

关键产业趋势包括推出先进的柔性输尿管镜取石系统和高能量雷射平台，目的是提高手术效率和安全性。雷射碎石技术在新兴市场的推广应用，进一步提升了医疗器材的普及率，并增强了全球製造商的竞争力。

报告范围

《全球肾结石治疗市场》报告详细分析了市场规模、依类型和最终用户划分的市场细分、区域趋势、技术趋势、竞争策略和新产品发布。本报告评估了影响泌尿外科设备市场在2025年、2026年和2034年发展的成长因素、营运挑战、医疗政策影响以及手术应用模式，为泌尿外科设备行业的製造商、医疗服务提供者、投资者和策略规划人员提供全面的洞察。

输尿管镜、雷射碎石术和数位成像平台的技术进步显着提高了手术成功率，减少了併发症，缩短了恢復时间，促使医院和专科诊所升级其泌尿外科设备。输尿管镜领域在2026年的市场占有率将达到 51.59%，而医院的市场占有率也将达到 55.89%，这凸显了人们对先进的、以医疗机构为基础的治疗方案的持续偏好。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

• 市场驱动因素
• 市场限制因素
• 市场机会

第4章 主要考察

• 主要国家和地区的偿付情况
• 肾结石治疗设备的最新进展
• 主要行业趋势
• 主要产业趋势：併购、业务合作
• 新冠疫情对肾结石治疗设备市场的影响

第5章 全球肾结石治疗市场分析、洞察与预测（2021-2034）

• 关键分析/摘要
• 市场分析、洞察与预测：依类型划分
  • 体外震波碎石术
  • 输尿管镜检查
  • 经皮肾镜取石术（PCNL）
• 市场分析、洞察与预测：依最终用户划分
  • 医院
  • 专科诊所
  • 门诊手术中心
• 市场分析、洞察与预测：依地区划分
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第6章 北美肾结石治疗市场分析：洞察与预测（2021-2034）

• 依国家划分
  • 美国
  • 加拿大

第7章 欧洲肾结石治疗市场分析：洞察与预测（2021-2034）

• 依国家划分
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 斯堪的纳维亚
  • 欧洲其他地区

第8章 亚太地区肾结石治疗市场分析：洞察与预测（2021-2034）

• 依国家划分
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 东南亚亚洲
  • 亚太其他地区

第9章 拉丁美洲肾结石治疗市场分析：洞察与预测（2021-2034）

• 依国家划分
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第10章 中东与非洲肾结石治疗市场分析：洞察与预测（2021-2034）

• 依国家划分
  • GCC各国
  • 南非
  • 中东和非洲其他地区

第11章 竞争分析

• 主要行业趋势
• 全球市场占有率分析（2021）
• 竞争格局概览
• 主要参与者比较分析
• 公司简介
• Cook Medical Inc.
• Olympus Corp.
• C.R. Bard Inc.
• Boston Scientific Corporation
• STORZ MEDICAL AG
• Richard Wolf GmbH
• Lumenis
• EDAP TMS
• DirexGroup
• DirexGroup
• 其他主要参与者

第12章 策略建议

Growth Factors of kidney stone management Market

The global kidney stone management market size was valued at USD 1.98 billion in 2025. The market is projected to grow to USD 2.09 billion in 2026 and further reach USD 3.37 billion by 2034, reflecting steady expansion driven by increasing disease prevalence and rising adoption of minimally invasive treatment procedures. North America dominated the kidney stone management market with a 36.03% market share in 2025, supported by advanced healthcare infrastructure, higher diagnosis rates, and strong availability of technologically advanced medical devices.

Kidney stone disease, also known as nephrolithiasis, affects a significant portion of the adult population, with recurrence rates exceeding 30% within ten years. The growing burden of obesity, diabetes, hypertension, and sedentary lifestyles is increasing the risk of stone formation, thereby driving sustained demand for kidney stone treatment devices across hospital and outpatient settings.

Market Drivers and Growth Factors

The increasing preference for minimally invasive surgical techniques is one of the strongest drivers of the kidney stone management market. Procedures such as ureteroscopic lithotripsy, extracorporeal shock wave lithotripsy, and percutaneous nephrolithotomy are widely adopted due to reduced post-operative pain, lower complication rates, shorter hospital stays, and quicker recovery times. Surgeons are shifting away from open surgeries, leading to higher procedural volumes and greater device utilization.

Technological advancements in flexible fiber-optic ureteroscopes, digital imaging systems, and laser lithotripsy platforms are improving procedural accuracy and clinical success rates. Innovations such as high-energy holmium laser systems allow efficient stone fragmentation with minimal damage to surrounding tissues, improving treatment outcomes and driving hospital investment in advanced urology equipment.

Market Restraints and Challenges

Despite technological progress, certain treatment approaches present limitations. Shock wave lithotripsy is associated with risks such as renal tissue damage, bleeding, urinary obstruction, and possible increases in arterial blood pressure. These side effects can restrict patient eligibility and physician preference in certain cases, limiting broader adoption in complex stone conditions.

Cost barriers also affect adoption in developing regions, where healthcare budgets remain constrained and access to advanced surgical devices is limited. In addition, lack of specialized urology infrastructure in rural healthcare facilities reduces procedural availability, particularly in emerging economies.

Impact of COVID-19 on the Market

The COVID-19 pandemic caused temporary disruption to kidney stone management services. Elective urology procedures were postponed, diagnostic visits declined, and healthcare resources were redirected toward emergency and infectious disease management. Medical device manufacturing and global supply chains also experienced slowdowns, resulting in delayed equipment procurement. Although demand recovered post-pandemic, procedural backlogs created short-term fluctuations in device utilization across hospitals and ambulatory surgical centers.

Segmentation Analysis

By Type

The market is segmented into lithotripsy, ureteroscopy, and percutaneous nephrolithotomy (PCNL). Among these, the ureteroscopy segment dominated with a 51.59% market share in 2026. This dominance is supported by high stone clearance rates, reduced recurrence risk, and strong suitability for both small and moderate-sized stones. Continuous improvements in scope flexibility, imaging clarity, and laser compatibility further strengthen adoption.

By End User

Based on end users, the market includes hospitals, specialty clinics, and ambulatory surgical centers. Hospitals accounted for the largest share at 55.89% in 2026, driven by higher patient volumes, access to full surgical facilities, and broader insurance coverage. Specialty clinics are gaining traction due to focused urology expertise, growing outpatient procedural capacity, and favorable reimbursement policies in selected countries.

Regional Market Insights

North America

North America recorded a market size of USD 0.71 billion in 2025, maintaining regional leadership due to strong diagnostic penetration, favorable reimbursement systems, and rapid technology adoption. The U.S. kidney stone management market is projected to reach USD 0.68 billion by 2026, supported by widespread use of minimally invasive procedures and high disease prevalence.

Europe

Europe holds the second-largest regional share, driven by rising incidence rates and increasing healthcare expenditures. By 2026, the Germany market is projected to reach USD 0.16 billion, while the UK market is projected to reach USD 0.07 billion, supported by high acceptance of advanced urology devices and structured referral systems within public healthcare networks.

Asia Pacific

Asia Pacific is expected to show strong expansion due to large patient populations and improving healthcare access. By 2026, the China market is projected to reach USD 0.14 billion, the Japan market USD 0.11 billion, and the India market USD 0.05 billion. Rising awareness, increasing hospital investments, and expanding private healthcare services are strengthening device demand across urban treatment centers.

Latin America and Middle East & Africa

These regions are experiencing gradual growth supported by improving healthcare infrastructure and increasing disease awareness. Expansion of hospital networks and international medical device partnerships is improving access to kidney stone management technologies.

Competitive Landscape and Industry Developments

The market is led by companies such as Boston Scientific Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Cook Medical, Lumenis, and EDAP TMS. These players maintain strong global presence through diversified product portfolios, continuous innovation, and strategic partnerships.

Key industry developments include the launch of advanced flexible ureteroscopic retrieval systems and high-energy laser platforms designed to improve procedural efficiency and safety. Expansion of laser lithotripsy technologies in emerging markets has further increased device penetration and competitive positioning among global manufacturers.

Report Coverage

The kidney stone management market report provides in-depth analysis of market size, segmentation by type and end user, regional performance, technology trends, competitive strategies, and recent product launches. The report evaluates growth factors, operational challenges, healthcare policy influences, and procedural adoption patterns shaping market development between 2025, 2026, and 2034, offering comprehensive insights for manufacturers, healthcare providers, investors, and strategic planners operating within the urology device industry.

Conclusion

The kidney stone management market is demonstrating steady and sustained expansion, with the global market valued at USD 1.98 billion in 2025, projected to reach USD 2.09 billion in 2026, and expected to grow further to USD 3.37 billion by 2034. This growth trajectory is strongly supported by the rising global prevalence of kidney stone disease, high recurrence rates, and increasing adoption of minimally invasive treatment procedures across healthcare systems.

Technological advancements in ureteroscopy, laser lithotripsy, and digital imaging platforms are significantly improving procedural success rates, reducing complications, and shortening recovery times, which is encouraging hospitals and specialty clinics to upgrade their urology equipment. The dominance of the ureteroscopy segment, holding 51.59% market share in 2026, and the strong position of hospitals with 55.89% share in 2026, highlight the continued preference for advanced, facility-based treatment options.

Segmentation By Type

• Lithotripsy
• Ureteroscopy
• Percutaneous Nephrolithonomy (PCNL)

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Geography

• North America (the U.S., and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Reimbursement Scenario by Key Countries/Region
• 4.2. Recent Advancements in Kidney Stone Management Devices
• 4.3. Key Industry Trends
• 4.4. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• 4.5. Impact of COVID-19 on Kidney Stone Management Devices Market

5. Global Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Lithotripsy
  • 5.2.2. Ureteroscopy
  • 5.2.3. Percutaneous Nephrolithonomy (PCNL)
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals
  • 5.3.2. Specialty Clinics
  • 5.3.3. Ambulatory Surgical Centers
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Type
  • 6.2.1. Lithotripsy
  • 6.2.2. Ureteroscopy
  • 6.2.3. Percutaneous Nephrolithonomy (PCNL)
• 6.3. Market Analysis - By End User
  • 6.3.1. Hospitals
  • 6.3.2. Specialty Clinics
  • 6.3.3. Ambulatory Surgical Centers
• 6.4. Market Analysis - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Type
  • 7.2.1. Lithotripsy
  • 7.2.2. Ureteroscopy
  • 7.2.3. Percutaneous Nephrolithonomy (PCNL)
• 7.3. Market Analysis - By End User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
  • 7.3.3. Ambulatory Surgical Centers
• 7.4. Market Analysis - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Type
  • 8.2.1. Lithotripsy
  • 8.2.2. Ureteroscopy
  • 8.2.3. Percutaneous Nephrolithonomy (PCNL)
• 8.3. Market Analysis - By End User
  • 8.3.1. Hospitals
  • 8.3.2. Specialty Clinics
  • 8.3.3. Ambulatory Surgical Centers
• 8.4. Market Analysis - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Type
  • 9.2.1. Lithotripsy
  • 9.2.2. Ureteroscopy
  • 9.2.3. Percutaneous Nephrolithonomy (PCNL)
• 9.3. Market Analysis - By End User
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
  • 9.3.3. Ambulatory Surgical Centers
• 9.4. Market Analysis - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Type
  • 10.2.1. Lithotripsy
  • 10.2.2. Ureteroscopy
  • 10.2.3. Percutaneous Nephrolithonomy (PCNL)
• 10.3. Market Analysis - By End User
  • 10.3.1. Hospitals
  • 10.3.2. Specialty Clinics
  • 10.3.3. Ambulatory Surgical Centers
• 10.4. Market Analysis - By Country/Sub-region
  • 10.4.1. GCC Countries
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2021)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, Strategies, Financials (based on availability))
  • 11.5.1. Cook Medical Inc.
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & Services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. Strategies,
    • 11.5.1.6. Financials (based on availability)
  • 11.5.2. Olympus Corp.
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & Services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. Strategies,
    • 11.5.2.6. Financials (based on availability)
  • 11.5.3. C.R. Bard Inc.
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & Services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. Strategies,
    • 11.5.3.6. Financials (based on availability)
  • 11.5.4. Boston Scientific Corporation
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & Services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. Strategies,
    • 11.5.4.6. Financials (based on availability)
  • 11.5.5. STORZ MEDICAL AG
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & Services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. Strategies,
    • 11.5.5.6. Financials (based on availability)
  • 11.5.6. Richard Wolf GmbH
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & Services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. Strategies,
    • 11.5.6.6. Financials (based on availability)
  • 11.5.7. Lumenis
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & Services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. Strategies,
    • 11.5.7.6. Financials (based on availability)
  • 11.5.8. EDAP TMS
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & Services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. Strategies,
    • 11.5.8.6. Financials (based on availability)
  • 11.5.9. DirexGroup
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products & Services,
    • 11.5.9.3. SWOT analysis,
    • 11.5.9.4. Recent developments,
    • 11.5.9.5. Strategies,
    • 11.5.9.6. Financials (based on availability)
  • 11.5.10. Other prominent players
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products & Services,
    • 11.5.10.3. SWOT analysis,
    • 11.5.10.4. Recent developments,
    • 11.5.10.5. Strategies,
    • 11.5.10.6. Financials (based on availability)

12. Strategic Recommendations

List of Tables

• Table 1: Global Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
• Table 2: Global Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
• Table 3: Global Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Region, 2021-2034
• Table 4: North America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
• Table 5: North America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
• Table 6: North America Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country, 2021-2034
• Table 7: Europe Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
• Table 8: Europe Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
• Table 9: Europe Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
• Table 10: Asia Pacific Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
• Table 11: Asia Pacific Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
• Table 12: Asia Pacific Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
• Table 13: Latin America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
• Table 14: Latin America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
• Table 15: Latin America Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
• Table 16: Middle East & Africa Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
• Table 17: Middle East & Africa Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
• Table 18: Middle East & Africa Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

• Figure 1: Global Kidney Stone Management Market Revenue Breakdown (US$ Bn, %) by Region, 2025& 2034
• Figure 2: Global Kidney Stone Management Market Value Share (%), by Type, 2025& 2034
• Figure 3: Global Kidney Stone Management Market Forecast (US$ Bn), by Lithotripsy, 2021-2034
• Figure 4: Global Kidney Stone Management Market Forecast (US$ Bn), by Ureteroscopy, 2021-2034
• Figure 5: Global Kidney Stone Management Market Forecast (US$ Bn), by Percutaneous Nephrolithonomy (PCNL), 2021-2034
• Figure 6: Global Kidney Stone Management Market Value Share (%), by End-user, 2025& 2034
• Figure 7: Global Kidney Stone Management Market Forecast (US$ Bn), by Hospitals, 2021-2034
• Figure 8: Global Kidney Stone Management Market Forecast (US$ Bn), by Specialty Clinics, 2021-2034
• Figure 9: Global Kidney Stone Management Market Forecast (US$ Bn), by Ambulatory Surgical Centers, 2021-2034
• Figure 10: Global Kidney Stone Management Market Value (US$ Bn), by Region, 2025& 2034
• Figure 11: North America Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
• Figure 12: North America Kidney Stone Management Market Value Share (%), by Type, 2025
• Figure 13: North America Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
• Figure 14: North America Kidney Stone Management Market Value Share (%), by End-user, 2025
• Figure 15: North America Kidney Stone Management Market Value (US$ Bn), By Country, 2025& 2034
• Figure 16: North America Kidney Stone Management Market Value Share (%), By Country, 2025
• Figure 17: Europe Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
• Figure 18: Europe Kidney Stone Management Market Value Share (%), by Type, 2025
• Figure 19: Europe Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
• Figure 20: Europe Kidney Stone Management Market Value Share (%), by End-user, 2025
• Figure 21: Europe Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
• Figure 22: Europe Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
• Figure 23: Asia Pacific Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
• Figure 24: Asia Pacific Kidney Stone Management Market Value Share (%), by Type, 2025
• Figure 25: Asia Pacific Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
• Figure 26: Asia Pacific Kidney Stone Management Market Value Share (%), by End-user, 2025
• Figure 27: Asia Pacific Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
• Figure 28: Asia Pacific Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
• Figure 29: Latin America Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
• Figure 30: Latin America Kidney Stone Management Market Value Share (%), by Type, 2025
• Figure 31: Latin America Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
• Figure 32: Latin America Kidney Stone Management Market Value Share (%), by End-user, 2025
• Figure 33: Latin America Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
• Figure 34: Latin America Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
• Figure 35: Middle East & Africa Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
• Figure 36: Middle East & Africa Kidney Stone Management Market Value Share (%), by Type, 2025
• Figure 37: Middle East & Africa Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
• Figure 38: Middle East & Africa Kidney Stone Management Market Value Share (%), by End-user, 2025
• Figure 39: Middle East & Africa Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
• Figure 40: Middle East & Africa Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
• Figure 41: Global Kidney Stone Management Market Share (%), By Company, 2025